CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −22,151 | $35.29 | $782K | 223,901 |
| 2023-03-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −5,538 | $35.29 | $195K | 86,300 |
| 2023-03-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −22,151 | 1,074,364 | ||
| 2023-03-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,901 |
| 2023-03-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −32,000 | $35.81 | $1.1M | 223,901 |
| 2023-03-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,000 | $35.81 | $286K | 91,838 |
| 2023-03-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,096,515 | ||
| 2023-03-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,901 |
| 2023-03-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −32,000 | $36.25 | $1.2M | 223,901 |
| 2023-03-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,000 | $36.26 | $290K | 99,838 |
| 2023-03-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,128,515 | ||
| 2023-03-03 | Schlanger David J Executive Chairman | Exercise or conversion | +41,666 | $0.91 | $38K | 117,834 |
| 2023-03-03 | Schlanger David J Executive Chairman | Sale | −41,666 | $36.26 | $1.5M | 76,168 |
| 2023-03-03 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −41,666 | 732,228 | ||
| 2023-03-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Grant or award | +7,000 | 63,949 | ||
| 2023-03-02 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-03-02 | Sturmer Michael E PRESIDENT | Grant or award | +7,000 | 210,881 | ||
| 2023-03-02 | Sturmer Michael E PRESIDENT | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-03-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,901 |
| 2023-03-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −25,758 | $35.97 | $927K | 230,143 |
Page 28 of 77 · 1,524 trades